A 28-year-old man with a history of transfusion-dependent thalassemia major presents to the hematology clinic for routine follow-up. He has received 35 units of packed red blood cells over the past 5 years. Today, his blood type is confirmed as B Rh-positive. During pre-transfusion testing, the indirect antiglobulin test (IAT) is positive, and panel testing reveals antibodies against the Kidd(a) antigen. The blood bank informs you that B Rh-positive blood lacking Kidd(a) antigen is available. Which of the following best explains the positive IAT and identifies the next appropriate transfusion strategy?

Explanation

## Alloimmunization in Transfusion-Dependent Patients This patient exemplifies a common complication of chronic transfusion: **alloimmunization** to non-ABO, non-Rh blood group antigens. ### Key Point: **Alloimmunization occurs in 5–10% of transfusion-dependent patients after multiple transfusions.** The Kidd(a) antigen is a frequent target, particularly in patients with thalassemia and sickle cell disease. ### High-Yield: Indirect Antiglobulin Test (IAT) Interpretation | Finding | Interpretation | Clinical Action | |---------|---|---| | **Positive IAT + panel identifies specific antigen** | Alloimmunization (IgG antibody) | Transfuse antigen-negative blood | | **Positive IAT + no specific antigen identified** | Autoimmune hemolytic anemia (warm IgG) | Direct antiglobulin test (DAT) confirms; transfuse least incompatible blood | | **Positive IAT + cold-reactive IgM** | Cold agglutinin disease | Transfuse warmed blood; clinically less significant | ### Mnemonic: **KIDD** (Kidd Antigen Alloimmunization in Dependent Donors) - **K**idd antigen is immunogenic (5–10% alloimmunization rate) - **I**mmune response is IgG (detected by IAT) - **D**ependent patients (thalassemia, SCD) at highest risk - **D**irect antiglobulin test (DAT) is negative (rules out autoimmune hemolysis) ### Clinical Pearl: In this patient, the **DAT would be negative** (unlike autoimmune hemolytic anemia), confirming that the positive IAT reflects alloimmunization rather than autoimmune hemolysis. The panel identifies Kidd(a) as the culprit antigen. ### Management Strategy: ```mermaid flowchart TD A[Transfusion-dependent patient]:::outcome --> B{Positive IAT?}:::decision B -->|Yes| C[Perform panel testing]:::action C --> D{Specific antigen identified?}:::decision D -->|Yes| E[Alloimmunization]:::outcome D -->|No| F[Perform DAT]:::action F --> G{DAT positive?}:::decision G -->|Yes| H[Autoimmune hemolytic anemia]:::outcome G -->|No| I[Cold agglutinin disease]:::outcome E --> J[Transfuse antigen-negative blood]:::action H --> K[Transfuse least incompatible]:::action I --> L[Transfuse warmed blood]:::action ``` ### Why Kidd(a)-Negative Blood? The patient has IgG anti-Kidd(a) antibodies. Transfusing Kidd(a)-positive blood would cause a **delayed hemolytic transfusion reaction** (typically 3–7 days post-transfusion) due to anamnestic IgG response. Kidd(a)-negative blood avoids this antigen entirely. [cite:Harrison 21e Ch 179; Robbins 10e Ch 4]